Aug. 13 at 12:20 PM
$SMTI
🚨 🚨
Revenue:
$25.8 million, surpassing the estimated
$25.15 million, marking a 28% increase year-over-year.
Net Loss: Reduced to
$2.0 million from
$3.5 million in the same quarter of 2024, indicating improved financial performance.
Adjusted EBITDA: Achieved
$2.7 million, a significant rise from
$0.6 million in the second quarter of 2024.
Gross Margin: Improved to 93% from 90% in the previous year, driven by increased sales and lower manufacturing costs.
Cash Flow: Generated
$2.7 million from operating activities, compared to a cash outflow of
$1.4 million in the prior year.
Sanara Surgical Segment: Reported a net income of
$0.5 million, a turnaround from a
$2.2 million loss in the previous year.
